Value of proBNP1–108 testing for the risk stratification of patients with systolic heart failure.

Highlights: [•] ProBNP1–108, BNP and Nt-proBNP levels were measured in patients with systolic heart failure (HF). [•] Their predictive value for long-term survival was assessed through an 8 years follow-up. [•] ProBNP1–108 levels were markedly increased in patients with systolic HF. [•] The highest proBNP levels were related to patients with the highest risk of CV death. [ABSTRACT FROM AUTHOR]